🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-20
Trial ID
NCT02293395
Treatments Being Tested
The use of acetylsalicylic acid in the primary prevention of cardiovascular...
Status
Completed
Location
Multiple Locations
Start Date
2007-07-05
Trial ID
NCT00501059
Treatments Being Tested
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leadi...
Status
Recruiting
Location
Taichung Veterans General Hospital
Start Date
2025-05-05
Trial ID
NCT06935994
Treatments Being Tested
This is a prospective, randomized, double-blind, double-dummy, and controll...
Status
Withdrawn
Location
Central Army Hospital RSPAD Gatot Soebroto
Start Date
2015-11
Trial ID
NCT02146664
The purpose of this study is to provide information of the relative potency...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2006-08
Trial ID
NCT00357968
Treatments Being Tested
The purpose of this study is to conduct a single-center, randomized, open-l...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2019-06-21
Trial ID
NCT04434365
Treatments Being Tested
BCAIS-I is a single-center, randomized, double-blind, dose-response control...
Status
Recruiting
Location
Zhujiang Hospital of Southern Medical University
Start Date
2025-02-10
Trial ID
NCT06712004
Treatments Being Tested
The goal of this clinical trial is to compare the pharmacokinetics (PK) pha...
Status
Terminated
Location
Omega Research Orlando, LLC
Start Date
2023-03-11
Trial ID
NCT05625347
An open label, balanced, randomized, three-treatment, three-period, six-seq...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-14
Trial ID
NCT01847404